Crossref

1. Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study

- Mohammad Tasavon Gholamhoseini

- Heidar Sharafi

- Helena HL Borba

- Seyed Moayed Alavian

- Asma Sabermahani

- Behzad Hajarizadeh

2. Prevalence of hepatitis C virus NS5A resistance-associated substitutions in chronic infection with genotype 1: A pooled analysis based on deposited sequences in GenBank

- Heidar Sharafi

- Saeideh Maleki

- Seyed Moayed Alavian

3. Treatment of HCV Infection with Direct-Acting Antiviral Agents in Patients with HIV/HCV Co-Infection: A Systematic Review

- Saman Mohazzab-Torabi

- Fardin Dolatimehr

- Heidar Sharafi

- Mahdi Safi-Abadi

- Mohammad Saeid Rezaee-Zavareh

- Ehsan Bayatpour

- Hamidreza Karimi-Sari

- Seyed Moayed Alavian

4. Comment on ‘Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO study’

- Seyed M. Alavian

- Heidar Sharafi

5. Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disorders

- Heidar Sharafi

- Bita Behnava

- Alireza Azizi-saraji

- Ali Namvar

- Ali Anvar

- Shima Salimi

- Seyed Moayed Alavian

6. Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting

- Heidar Sharafi

- Hossein Poustchi

- Fatemeh Azimian

- Babak Tamadoni

- Rashid Ramezani

- Mohamad Mehdi Gouya

- Mahdi Sheikh

- Farnaz Hashemi

- Mehrzad Tashakorian

- Ramin Alasvand

- Seyed Moayed Alavian

- Shahin Merat

7. Pooled Prevalence of NS5A Resistance-Associated Substitutions in Chronic HCV Genotype 3 Infection: A Study Based on Deposited Sequences in GenBank

- Heidar Sharafi

- Saman Ghalamkari

- Alireza Hassanshahi

- Seyed Moayed Alavian

8. Prevalence of Naturally-Occurring NS5A and NS5B Resistance-Associated Substitutions in Iranian Patients With Chronic Hepatitis C Infection

- Pooneh Rahimi

- Heidar Sharafi

- Golnaz Bahramali

- FaridehSadat SajadianFard

- Nafiseh Sadat Asadi

- Seyed Moayed Alavian

- Vahid Iranpur Mobarakeh

- Seyedeh Zahra Moravej

9. Hepatitis C resistance to NS5A inhibitors: Is it going to be a problem?

- Heidar Sharafi

- Seyed Moayed Alavian